Changes in weight and BMI with first-line doravirine-based therapy

To evaluate changes in weight and BMI in adults with HIV-1 at 1 and 2 years after starting an antiretroviral regimen that included doravirine, ritonavir-boosted darunavir, or efavirenz. DESIGN: Post-hoc analysis of pooled data from three randomized controlled trials. METHODS: We evaluated weight cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Orkin, Chloe, Elion, Richard, Thompson, Melanie, Rockstroh, Juergen K., Alvarez Bognar, Fernando, Xu, Zhi J., Hwang, Carey, Sklar, Peter, Martin, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752237/
https://www.ncbi.nlm.nih.gov/pubmed/33048879
http://dx.doi.org/10.1097/QAD.0000000000002725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752237/
https://www.ncbi.nlm.nih.gov/pubmed/33048879
http://dx.doi.org/10.1097/QAD.0000000000002725

Ejemplares similares